A B S T R A C T Using circulatinig mononuclear cells as a readily available tissue and using the rate of high af: finity degradation of 1251-labeled low density lipoprotein (LDL) as an index of' cell surface LDL receptor activity, we have measured receptor activity in cells from 53 individuals. This group includes 32 healthy
suibjects, 15 subjects with the heterozygous forimi of famiiilial hvpercholesterolemia, anid 6 subjects with hyperlipidemic disorders other than familial hypercholesterolemia. 7 of the healthy subjects and 10 of the heterozygotes were members of a single large kindred with five-generation transmission ofthe mutant familial hypercholesterolemia gene. LDL receptor activity was assayed in blood mononuclear cells unider two sets of conditions. First, 125I-LDL degradation was measured in puirified lymphocytes that had been incubated for 3 dax's in the absence of lipoproteins so as to induce a high level of LDL receptor activity. Phase-contrast autoradiograml-s of cells incubated with 1251-LDL and electron mnicrographs of cells incutbate(d with ferritinlabeled LDL confirmed the existence of LDL receptors on lymphocytes. Second, 1251-LDL degradation was measured in mixed monionucelear cells (85-90% lymphocytes and 5-15% monocytes) immediately after their isolationfrom the bloodstream. This assay represented an atteimipt to assess the number of receptors actually expressed oin the cells wheni they were in the circulation. Under both sets of conditions, cells from the familial hypercholesterolemia heterozygotes expressed an average of about onie-half the inormal numnber of LDL receptors. The current findings are consistent with the conclusion that heterozygotes with familial hypercholesterolemia possess only one functional allele at the Doctors Bilheiimer and Brown are Established Inivestigators of the Americain Heart Association.
INTRODUCTION
The primary genetic defect in familial hypercholesterolemia (FH)1 inivolves the genie encodinig a cellsturface receptor that normally binds the plasma cholesterol transport protein low density lipoproteini (LDL) (reviewed in refs. [1] [2] [3] [4] . Binding of LDL to the receptor is the initial event in a process by which human cells internalize the lipoprotein through adsorptive endocvtosis and degrade it within cellular lysosomes (5) . The genetic defect in the LDL receptor in FH was originally elucidated through studies of fibroblasts cultured from patients with the receptor-negative form of' homozygous FH (2, 5) . Cells from these subjects lack detectable LDL binding and hence they fail to take uip acnd degrade 1251-labeled LDL with high affinity.
In normal fibroblasts, the production of functionial LDL receptors is regulated so that the number of receptors is highest when the cells are deprived of cholesterol by incubation in medium containing lipoproteindeficient serum. Conversely, the nuimber of LDL receptors is lowest when fibroblasts have been incubated continuously in the presence of high levels of LDL (6) . Fibroblasts from FH heterozygotes have been shown to express about one-half the normal number of LDL receptors when incubated under culture conditions that elicit a maximal rate of receptor synthesis (1, 7) . Moreover, FH heterozygote cells suppress their receptor activity in parallel with normal cells so that these muttant cells continue to express half the number of LDL receptors that are expressed by normal cells even under 1 Abbreviatiotns used in this paper: FH, familial hypercholesterolemia; LDL, low density lipoprotein. The Jouirnal of Clinical Investigation Volume 61 March 1978 *678 -696 regulatory coniditions in which the numnber of LDL receptors in cells from both genotypes is made to vary widely (7) .
Recently, LDL receptors have been demonstrated oni the surface of peripheral blood lymphocytes isolated from normal subjects (8, 9) . As predicted from the studies of receptor regulation in fibroblasts, lymphocytes express only a relatively small number of receptors immediately after their isolation from the bloodstream where they have been exposed to high levels of LDL. However, when the freshly isolated lymphocytes are incubated in vitro in lipoprotein-deficient serum, the numl)er of LDL receptors inicreases up to 30-fold and the cells thereby acquire an increased ability to rapidly ingest and degrade 1251-LDL (8) . Lymphocytes from subjects with homozygous FH express less than 5% of the normal amount of LDL receptor activity after incubation for 72 h in lipoprotein-deficient serum (8, 9) .
The present studies were designed to compare the LDL receptor activity in lymphocytes from normal subjects and FH heterozygotes. Using the rate of high affinity degradation of 125I-LDL as an index of LDL receptor activity, and using a new set of rigidly standardized assay conditions, we have found that lymphocytes from FH heterozygotes express onlyr about onehalf the normal number of LDL receptors after incubation for 3 days in lipoprotein-deficient serum. Moreover, the data indicate that this twofold difference in LDL receptor activity between normal and FH heterozygote cells is also present when the cells are studied within 3 h after their isolationi from the bloodstreanm. This latter finding may have implications for the pathogenesis of the elevated plasma LDL-cholesterol level in heterozygous FH.
MNET11ODS
Materials. 1251-Sodium iodide (carrier-free) and [2-14C] acetic acid, sodium salt (59 mCi/mmol) were purchased from Amersham/Searle Corp. (Arlington Heights, Ill.). Lymphoprep was obtained from Accurate Chemical & Scientific Corp. (Hicksville, N. Y.). Plastic flasks and dishes were obtained from Falcon (Div. of Becton, Dickinson, and Co., Oxnard, Calif.). Polystyrene (latex) particles, 1.1 ,am in diameter, were obtained from Sigma Chemical Co. (St. Louis, Mo.). Tissue culture supplies and chemicals for assays were obtained f'rom sources as previously reported (8) .
Subjects and family studies. Clinical and biochemical data for each of the 53 subjects whose lymphocytes were studied are summarized in Table III . 28 of these subjects were members of four families with familial forms of hyperlipidemia. One of these, the D family, is a large kindred with heterozygous FH; it spans five generations and includes 176 descendanits of one couple ( Fig. 5 ). 90% of all living blood relatives in the D family were available for plasma lipid measurements. For those relatives living outside of the Dallas area, fasting blood samples for lipid measurements were obtained and mailed to Dallas as previously described (10) . The B family is a small family in which three subjects have the heterozygous form of FH. The C family comprises individuals with the heterozvgous anid homozygous forms of FH; the pedigree of this family has been published previously (11) . The S family is a large kindred wvith fam-ilial dysbetalipoproteinem-nia in which the hyperlipidemic subjects show either a type 3 or type 4 lipoprotein patterin. Blood for lymphocyte studies was obtaimed \vith the informiied consent of each subject or his or her parents.
Lipoproteins. Humani LDL (d 1.019-1.063 g/ml) andl humnan lipoproteini-deficienit serumll (d > 1.215 g/nml) were obtained f'rom the plasnma of individual healthy subjects and( prepared by differenitial ultracenitrifugationi (12) . The conicenitration) of LDL is expressed in terms of its protein content. 12511 labeled LDL (200-400 cpm/ng of protein) (13) and LDL-ferritin (t\vo to three ferritin cores per LDL particle) (14) were prepared by the refereniced methods.
Proteolytic degradatiotn of 251-LDL by lyImphocytes after intcbation in7 the absetnce of lipoproteinis (methtod A). Heparinized venous blood specimens (20-120( ml) were obtained from each subject after an overnight fast. Mononuclear cells were isolated from these blood specinmens under sterile coniditions b)y a previously described method in which Lymphoprep is used as the separation medium (8, 9) . The resulting mononuclear cells were washed three times by repeated centrif'ugation, and the wvashed cell pellets were suspended in mediumii A (RPMII 1640 mlediumiii with penicillin [100 U/ml] and streptomvcin [100 /ug/ml]) containing 10% (vol/vol) human lipoprotein-deficienit serum (final protein concentration, 5 mg/mil). An aliquot of this suspensioni was used to couniit the number of monioniuclear cells, and the volumne was adjusted so that the final conceintration of mononuclear cells wvas approxi-matel\v2 x 106 cells/mI. Ali(quots (14 ml) ofthis cell suspenision were placed in 75-clm12 plastic culture flasks that were incubated in a horizontal positioin for 67 h at 37°C in a humilidified (5% CO2) incubator. After this incubation period, 2-ml portions of the cell suispenisioni (conitaining about 1.6-1.8 x 1(6 nioniadherent lyrmphocytes/ml) were removed froml the 75-cm2 flask and transferred directly to 25-cm2 plastic cultture flasks. Each of these 25-cmI12 flasks then received 10 ul of soluition containiing 20 jig of' 1251-LDL to achieve a final coincentrationi of 10 ug of protein/nml. Half of the flasks also received a 26-fold excess of unilabeled LDL delivered in 25 ulI (final conicenitration, 260 Ag of protein/miil). The flasks were inciubated in a horizontal position for 6 h at 37C, after which the mediumi N was removed, the cells were sedimented by ceintr-ifugationi, andl the cointenit of 1251-labeled trichloroacetic acid-soluble (noniodide) material that had been formed by the cells and released into the mediuimi vas determined as previously described (8, 15) . A blank value due to the presence of simiall amounits of n1on1iodide acid-soluible material (<0.05% oftotal added radioactivity) in the 1251-LDL preparationis was determined by parallel incubation of appropriate conicenitrations of the lipoproteiin at 37°C in flasks containinig meditm A, lipoprotein-deficienit sermii, and 1O cells (8, 15) . Total degradation of 1251-LDL represents the amouint of'2.25I-LDL degraded by the cells to noniodide acid-soluble material in the absence of excess Ulllabeled LDL. High affinit-(i.e., receptor-mediated) degrada-tiOn of 1251-LDL is defined as that component of' the total that was in1hibited competitively by the presence of ain excess of unilabeled LDL (8) . This latter value was calculated by stibtracting the amouint of I251-LDL degraded in the presence of 260 jig/mil of unlabeled LDL (nonspecific degradation) fronll the amounit of '251-LDL degraded in the absence of unlabeled LDL (total degradationi). The data are expressed as the naniograms of 1251-LDL degraded in 6 h per milligram of total cell protein, the latter determined on the cell pellet after washing (8) . Valuies for replicate assays of '251-LDL degradationi varied b) less than 5%.
Since the cells were transferred from stock 75-cm2 flasks to the 25-cm2 incubation flasks before incubation with '251-LDL, the mononuclear cells that had adhered to the plastic stock flask during the initial 67-h incubation were left behind. As a resuilt, more than 98% of the nonadherent cells incubated with 125I-LDL were identifiable as lymphocytes on the basis of the following criteria: (a) failure to ingest polystyrene particles or India ink (16) ; (b) morphological examination using  Wright-stained smears or phase-contrast microscopy (see Fig. 2); and (c) ultrastructural appearance as assessed by electron microscopy (see Fig. 1 ). More than 90% of the cells were viable by the criterion of erythrosin B exclusion. Proteolytic degradation of 125I-LDL by montoniuclear cells inmmediately after isolationfrom the bloodstreamin (method B). Mononuclear cells were isolated from heparinized blood and washed three times as described above. The washed cell pellets were resuspended in medium A conitainiing 30% (vol/vol) human lipoprotein-deficient serum (final protein concentration, 15 mg/ml), and the volume was adjusted so that the final concentration of mononuclear cells was 4 x 106 cells/ml. Portions (1 ml) of this cell suspension were placed into 35 x 10 mm petri dishes. Each dish received 10 Al of solution containing 25 ug of 125I-LDL (final concentration, 25 Ag of protein/ ml) in the absence or presence of a 20-fold excess of unlabeled LDL (final concentration, 500 utg of protein/ml). After incubation at 37°C for the indicated interval, the medium and cells were separated by centrifugation and the content of '251-labeled trichloroacetic acid-soluble (noniodide) material formed by the cells anid released into the mediumii was determined as described above for method A. The data are expressed as the nanograms of 1251-LDL degraded in 4 h per dish (4 x 106 cells). Values for replicate assays varied by less than 5%.
By the functional criterion of polystyrene particle ingestion (16) , the mononuclear cells used for the above studies consisted of a mixture of lymphocytes (85-95% of total cells) and monocytes (5-15% of total cells).
Electron microscopy. Mononuclear cells were isolated from venous blood obtained from a healthy subject (no. 21) and incubated for 67 h in lipoprotein-deficienit serum according to method A. Aliquots (2 ml) of the nonadherent lymphocytes were then transferred to 25-cm2 flasks and the cells were incubated with LDL-ferritin at an LDL-protein concentrationi of 50 ug/ml for 3 h at 37°C in the absence or presence of 500 mg of protein/ml of unlabeled LDL. After inculbation the cells were collected by centrifugation (1,700 epm, 5 min 4°C) in a siliconized plastic tube (12 x 75 mm). Each cell pellet was then suspenided in 75 gl of an albumini-conitaininig buffer (140 mM NaCl; 3 mM KCl; 50 uMl CaCl2; 1 mM KH2PO4; 8 mM Na2HPO4; and 20 mg/ml of bovine serum albumin, pH 7.2). The cell suspension was then layered onto I ml of 100% fetal calf serum in a siliconized plastic tube (12 x 75 mm) and centrifuged (1,700 rpm, 5 min 4°C). The resulting cell pellet was fixed with 1 ml of 2% glutaraldehyde in 0.1 M sodiunphosphate (pH 7.3), postfixed with 1% osmium tetroxide, dehydrated, and embedded in Araldite. The fixed pellets were sectioned, stained with uranyl acetate an(d lead citrate, and viewed with a Philips 300 electron microscope (Philips Electronic. Instrumenits, Inc., Mahwah, N. J.). The number ofmembrane-bound ferritini cores was counted bv a modificatioln of the (quanititative methods previously described (14, 19) .
Phase-cotntrast autoradiographty. Mon1onuclear cells wvere isolated from venous blood obtained from a healthy subject (no. 16) arid incubated for 67 h in lipoprotein-deficient serumil accordinig to method A. Ali(quots (2 ml) of the noniadherent lymphocytes wvere then transferredl to 25-cm2 flasks, and the cells were incuibated with 10 ug of protein/iil of 125-LDL (272 cpm/nig) either in the absence or preseniee of 470 ug of protein/ml of unlabeled LDL for 2 h at 37°C. After incubation the cells were collected bv centrifugationi (1, 700 rpm, 5 m,in 4°C) in a siliconiized plastic tube (12 x 75 mm). Eacih cell pellet was theni resuspenided in 0.2 mnl of mlediumn A conitaininig 10% fetal calf serum. The cell suspenision was theni layered onto 1.5 ml of 100% fetal calf serum in a siliconized plastic tube (12 x 75 mm) and centrifuiged (1,700 rpmi, 5 mil, 4°C). Each resulting cell pellet was washed with 2 ml of mleditunm A, and the final pellet wvas suspen(led in 0.6 ml of medlitum A containing 1% fetal calf serum so that the coneenitrationi of lymphocytes was 2 x 106 cells/ml. About 1(6 cells wvas then spun onto a glass microscope slide in a Shandoni Elliott Cytocenitrifuge (NIodel SCA-0025, Shandon Southerni Instrumieints, Ltd., Camberlev, Surrey, England). The slides were immersed in 2% glutaraldehyde in 0.1 M sodiuim phosphate buffer (pH 7.3) for 10 min at room temperatture, washed xvith distilled water, air dried, ancd dipped in a 1:2 dilutioni of Ilford L-4 liquiid photographic emulsion (Polysciences, Inc., Varrington, Pa.) in the darkrooml andl alloweed to air dry. The emiiulsionicoated slides were store(d in light-tight b)oxes containinlg Drierite dessicant at 4°C for 3 mo. The slides were then developed with D19-B developer, rinsed in distilled water, fixed with Rapid-Fix (Eastman Kodak Co., Rocheste-, N. Y.), and examined and photographed under phase optics tusing an American Optical Microstar 10 e(quiipped with a Polaroidl camera.
Othler ass(lays. The coneenitration of total cholesterol au(I total triglycerides in plasma and in isolate(d lipoprotein fractionis wvas determinied b\ enz\yFme methods (Boehringer Mannlheim Biochemicals, Indiancapolis Ind., ciatalog nos. 124087 and 124966 for cholesterol and triglycerides, respectively). Precilip conitrol serum (Boehringer Mlannheim, Catalog no. 125059) was used for standardizatioin. Lipoproteinicholesterol concentrationis in plasnma were oletermiiiied by FIGURE 1 Electron micrographs of normal lymphocytes incutbate(d in lipoprotein-deficieint serum for 67 h and then exposed to LDL-ferritin. Nonadherent lymphocytes wvere isolated and incubated with LDL-ferritin at an LDL-proteiin concentration of 50 ,.ig/ml for 3 h at 37°C as described in Methods. After incubation, the cells were prepared for electroni microscopy as described in Methods. (A) A low magniificationi view of nonadherent lymphocytes. These cells exhibit the typical size and appearance of smlall and mediumni-size lvmphocytes (20) . x7,000. (B) A high magnification view of the lymphocyte cell surface. Typically, LDL-ferritin was observed to localize in inidented regionis of the plasmiia memiibranie (arrow).
The dark area at the bottom of the mnicrograph is nuclear chromiiatiin. x 112,500. (C) A more deeply invaginiated segmenit of the lymphocyte plasmia membrane, showing the localization of LDL-ferritin within these indented regions. x97,000. (D) A nevly forimied endocytic vesicle that contains LDL-ferritin. This endocytic vesicle has a well-definied cytoplasmic coat (arrows). x154,000. (E) A lymphocyte lysosonme that has acctumulated ferritin cores derived from the binding and uptake of LDL-ferritiin. The ferritin cores are located onl the right side of this organelle. The left side contains electroin-dense material that is characteristic of lvsosomes and is not related to LDL-ferritin. x74,500.
A.-I , B C standard ultracentrifugation techniques combined with heparin-manganese precipitation (17) .
Total and differential leukocyte counts in blood specimens were performed according to standard clinical hematology techniques using a Coulter counter and Wright-stained smears.
The rate of incorporation of [2-'4C]acetate into cholesterol by lymphocytes was measured by method 2, as previously described (9) .
Protein was determined by the method of Lowry et al. (18) , with bovine seruim albumin as a standard.
RESULTS
To measure the ability of cells to produce LDL receptors in response to lipoprotein deprivation, we established a standard set of conditions in which mononuclear cells were isolated from blood by differential sedimentation and incubated in stock flasks for 67 h in medium containing lipoprotein-deficient serum. At the end of this interval, replicate aliquots of cells from the stock flasks were transferred to small flasks and incubated with 1251-LDL. This transfer step served to remove the monocytes from the cell preparation since the latter adhered to the plastic surface of the stock flask and were left behind. As a result, the 1251-LDL degradation studies were performed on a population of cells that consisted almost entirely of nonadherent lymphocytes (8, 9) . Visualization of LDL binding and uptake in nonadherent lymphocytes. To demonstrate visually that the nonadherent lymphocytes were capable of binding LDL at the specific receptor site, we incubated the nonadherent cells with LDL that had been covalently coupled to ferritin. LDL-ferritin has been shown previously to bind to the LDL receptor in fibroblasts and to be a useful probe for electron microscopic studies (14, 19) . Fig. IA shows the appearance at low magnification of a preparation of lymphocytes isolated and incubated in the above manner. The cells exhibit the characteristic morphology of small and medium-sized lymphocytes (20) . Fig. lB shows that the plasma membrane of these lymphocytes contains binding sites for LDL-ferritin. As in fibroblasts (14, 19) , the LDL binding sites on lymphocytes were not uniformly distributed over the cell surface, but rather they were found in discrete clusters whether the incubation with LDLferritin was conducted at 37°C (Fig. IB) or at 4°C (data not shown). In lymphocytes, as in fibroblasts, these clusters of LDL binding sites tended to occur in regions where the plasma membrane was indented ( Fig. 1B and C). However, in contrast to the findings in fibroblasts (14, 19) , these indented regions in lymphocytes did not possess a distinct cytoplasmic coat that could be visualized by the staining methods employed. In addition to its appearance on the lyImnphocyte cell surface, the LDL-ferritin was found within endocvtic vesicles after incubation at 37°C. Although miiost of these vesicles appeared smooth-surfaced, an occasional one showed the classic appearance of a coated vesicle ( Fig. ID) . Abundant LDL-ferritin particles were also found within lysosomes of the lymphocyte after incubation at 37°C (Fig. 1E ).
To ensure that the LDL-ferritin was binding to the physiologic LDL receptor, we incubated the lymphocytes with LDL-ferritin in the absence or presence of an excess of unlabeled native LDL. The number of membrane-bound LDL-ferritin particles was counted using a modification of a previously described quantitative technique (14) . Table I shows that more than 90% of the LDL-ferritin binding was abolished when the LDL receptors were occupied by the excess native LDL in the incubation medium, indicating that the ferritin-labeled lipoprotein was binding to the physiologic LDL receptor.
We also used the technique of autoradiography to visualize LDL receptor activity on lymphocytes. Fig. 2 shows a series of phase-contrast micrographs of autoradiograms of nonadherent lymphocytes that were exposed to 1251-LDL in the absence ( Fig. 2A -D) or presence ( Fig. 2E ) of an excess of unlabeled LDL. Whiteappearing silver grains were located over most of the lymphocytes in the preparation, indicating that these cells had taken up 1251-LDL ( Fig. 2A-D) . When the incubations were conducted in the presence of an excess of unlabeled LDL, the number of silver grains appearing over the cells was markedly reduced ( Fig. 2E ), confirming that the visualized silver grains were attributable to uptake of 1251-LDL through the saturable receptor mechanism. Fig. 2D and E show some of the rare monocytes that were present in this preparation (<2% of total cells). Whenever these monocytes were observed, they were surrounded by clusters of small Phalse-conitrast micrographs of autoradiograms of normal lymphocytes incubated in lipoprotein-deficienit serum for 67 h and then exposed to 125I-LDL. Nonadherent lymphocytes were isolated and incubated with 10 ,ug of protein/mil of 1251-LDL (272 cpm/ng) either in the absence (A-D) of presence (E) of 470 ,ug of protein/ml of unlabeled LDL for 2 h at 37°C, as described in Mlethods. After incubation, the cells were prepared for autoradiography and examined by phase-contrast microscopy as described in Methods. In these whole cell preparations, the developed silver grains are located in the photographic emulsion above the cells. Therefore, wheni the cell is in focus, the silver grains, which usually have a dark appearance, are out of focus and appear as bright white dots. All of the pictures described below were taken so that the cell-associated silver grains appear white. (A-C) A series of micrographs that demonstrate the localization of 125I-LDL in lymphocytes. Silver grains are indicated by the arrows. x 1,000. (D) This micrograph shows one of the rare monocytes in this preparationi. This large cell is surrounded by several small lymphocytes. Silver grains are localized over both types of cells, but appear more concentrated over the lymphocytes. xl1,000. (E) These cells were incubated with 125I-LDL in the presence of an excess of unlabeled LDL.
The field consists of one of the rare monocytes surrounded by small lymphocytes. The appearance is similar to that in Fig. 2D except that the number of silver grains located over the lymphocytes is markedly reduced. x 1,000.
lymphocytes. The monocytes appeared to take up somewhat less 1251-LDL than did the lymphocytes (Fig.  2D) . Occasional platelets were observed, but these were never associated with silver grains (Fig. 2C ). 1251-LDL degradation int nonadherent lymnphocytes. The above ultrastructural and autoradiographic studies, coupled with previous biochemical studies (8, 9) , demonstrate directly that cells that have the morphologic appearance of lymphocytes and that neither ad-here to plastic nor ingest polystyrene particles express LDL receptors when incubated in the absence of lipoproteins. To obtain a quantitative estimate of the relative LDL receptor activity in such nonadherent lymphocytes as compared with the activity in the population of blood monocytes and other mononuclear cells that adhere to plastic, we performed the experiments shown in Table II Table III. 2 h at 37°C in a plastic culture dish, and the cells that remained in suspension were transferred to separate flasks. Fresh medium was added to the adherent cells that remained in the culture dish, and both the adherent and nonadherent cells were incubated separately for 67 h at 37°C in lipoprotein-deficient serum. At the end of this interval, the ability of the monocyte-rich adherent cells2 to degrade 125I-LDL was roughly the same as that ofthe nonadherent lymphocytes (Table II) .
To demonstrate that the LDL receptor was functional in both adherent and nonadherent cells, we measured the ability of LDL to suppress the synthesis of [14C] cholesterol from [14C]acetate (9) . After the cells had been incubated in the absence of lipoproteins for 57 h, the subsequent addition of LDL to the incubation medium led to a 90% reduction in the rate of cholesterol synthesis when measured 9 h later (Table IL) . The reduction was similar in both the nonadherent and adherent cells, indicating that the LDL receptors that developed in lymphocytes and monocytes were capable of supplying cholesterol to the cells.
The rate at which nonadherent lymphocytes de-graded 1251-LDL after incubation in the absence of lipoproteins was influenced by the number of cells present in the initial 67-h incubation flask. Up to a concentration of 2.5 x 106 cells/ml, the rate of 1251-LDL degradation was linearly proportional to the number of cells ( Fig. 3 ). Above this concentration, the rate of 1251-LDL degradation was reduced. Hence, in all experiments in which nonadherent lymphocytes were incubated for 67 h, the number of mononuclear cells added to the initial incubation flask was adjusted to a final concentration of about 2 x 106 cells/ml. The data in Fig. 4 compare the saturation curves for 1251-LDL degradation in lymphocytes from a normal subject and an FH heterozygote after incubation for 67 h in the absence of lipoproteins. As previously demonstrated (8, 15) , at low 1251-LDL concentrations the bulk of this degradation is attributable to a high affinity process that achieves saturation in the range of 50 ,g of LDL-protein/ml. Above this level, the rate of degradation rises in a more gradual fashion as the 125I_ LDL concentration is increased. The shapes of the curves in Fig. 4 resemble those previously obtained in cultured fibroblasts in which total 1251-LDL degradation is the sum of the receptor-mediated, saturable uptake process and a second uptake process that is nonsaturable and is attributable to bulk fluid endocytosis (15) . Saturation of the high affinity process for the degradation of 1251-LDL occurred at about the same LDL concentration in the normal and FH heterozygote lymphocytes. However, at each concentration of 1251. LDL the rate of degradation was lower in the FH heterozygote cells than in the normal cells.
To evaluate the quantitative difference between the FH heterozygote and normal cells in more detail, we established a set of standardized incubation conditions that permitted the study of lymphocytes from a large number of heterozygotes with FH. In this standardized assay the cells were incubated for 67 h in the absence of lipoproteins and then incubated for 6 h with 125I-LDL at a concentration that was below saturation for the receptor-mediated uptake process (10 ug of LDL protein/ml). The rate of high affinity 1251-LDL degradation was estimated by measurement of susceptibility of the degradation process to competition by unlabeled LDL. Most of the FH heterozygote lymphocytes were obtained from members of the D family whose pedigree is shown in Fig. 5 . The D family is a classic example of a large kindred with familial hypercholesterolemia as indicated by the following characteristics: (a) the mutant gene is transmitted in a dominant fashion through five generations; (b) tendon xanthomas and premature coronary atherosclerosis are present in a large proportion of the hypercholesterolemic adult relatives (see legend to Fig. 5 ); and (c) eight children under 10 yr of age have plasma cholesterol levels greater than 245 mg/dl (mean, 306 mg/dl; range 246-400 mg/dl). As in other large families with FH (21, 22), the members ofthe D family could be clearly separated into affected and unaffected relatives on the basis of total plasma cholesterol levels alone, thus giving a population of patients that could be independently identified as FH heterozygotes and a population of control subjects from the same family. When its members were so classified, the D family was found to contain a total of 28 living FH heterozygotes as defined by the plasma cholesterol cut-off values described in the legend to 1) filmilv. S(quiare svml)ols (F, *) refer to micales; circles (0, 0) refer to femllales. F'amily mebl)ers ablove age 20 with a total plasmiia cholesterol level above 285 mg/dl were considered to he FH heterozygotes (O, *). For subjects below age 20 the cult-off value for plasmiia cholesterol was 245 mg/dl (22, 26) . Stubjects with plasnma cholesterol levels belowv these values were considerecl niormal (0,0). Tendon xanthomas were present in the following f:amiiily members: 11-10, Ill-11, 111-16, 111-19, 111-21, and IV-15. The following hypercholesterolemnic sul)jects, 20 yr of age and older, were not available to be examinied for tendoIn xan1thom1Cas: 11-3, 11-14, 111-13, IV-5, and IV-36. Since all of the living descenidanits of 11-2, 11-5, 11-9, and 11-12 (indicated by O) had normal plasmiia cholesterol levels, these branches of the pedigree have been trunecated. The total number of normal descendants in each of these branches is indicate(d within the synmbol O.
the D family were available for lymiphocyte stuclies were studied (Table III) . One of these (subject 49 in (Table III) . ily, lymphocytes fromll five other FH heterozygotes fromii the C' fanily, one of whom (subject 48) is the mother of' a patienit with the receptor-negative form of homozygous FH and is thus an obligate heterozygote for this disease. The other heterozygote fromii the C family (subject 40) is the sister of the homozygote; she is a 14-yr-old girl whose plasma LDL-cholesterol level is consistently elevated and whose fibroblasts have been shown to contain a hallfniiormiial number of LDL receptors (unipublished observations). Subject 52 is the father of a receptor-defective FH homozygote anid is therefore an obligate heterozygote. Subject 51 is anl FH heterozvgote on the basis of classic cliniical findings (see Table III ); his relatives were nlot available for study. A series of healthy subjects was selected from aimiong unaffected familv members of the al)ove faimiilies and also from a population of normal volunlteers. In addition, we studied a separate group of control subjects that conisisted of patients who have hyperlipidemia of a type different from FH. Two of these latter subjects (subjects 33 and 34) had LDL levels above the normal range for the healthy subjects, but nonie of themii had LDL levels as high as the population of' FH heterozygotes. The clinical and biochemical data for all of the subjects whose lymphocytes were studied are given in Table III . In addition, body weight and height were measured for each subject in groups I-111, and total and differential blood leukocyte counlts were obtained. No correlations were observed betweeni any of these valties and the parameters of LDL metabolism that were studied.
The data in Table III show the values for the rate of 1251-LDL degradationi in lymphocytes friom each of the 53 subjects. All measuremeints were mlade uinder the standardized assax conditions described above after the cells had been incubated for 67 h in lipoproteindeficient serum. The mean value +SD for the rate of 125I-LDL degradation by the high affinity process in the 32 healthy subjects was 892+314 ng/6 h per img protein. In the 6 hyperlipidemic control subjects with disorders other than FH, the mean value ±SD was 972 +335, a value that was not significantly different from the healthy subjects. However, among the 15 FH heterozygotes, the mean value ±SD for the rate of high affinity '25I-LDL degradation was 309±105 ng/6 h per nmg protein. This valuie is approximately 35% of the mean value observed in normal subjects (P < 0.0001). Fig. 6 shows the plasma LDL-cholesterol values in each of these subjects plotted against the rate of high affinity degradation of 125I-LDL as measured in lymphocytes. Values for the FH heterozygotes are clustered in the upper left cornier of this plot and are encompassed by two lines. All of the FH heterozygotes had a rate of high affinity 1251-LDL degradation that was less than 500 ng/6 h per mg protein. The data in Fig. 6 also demonstrate that among the subjects contained within each group there was no direct relation between the plasmla LDL-cholesterol level and the capacity of lymphocytes to produice LDL receptors as meaisured by the rate of high affinity degr(C(latioi of 1251_ LDL after inicubation of the cells in lipoproteini-deficient serum for 67 h.
The capacity of lymphocytes to produice LDL receptors was independent of the age of the subjects (Table   III) . At all ages, the rate of high affinity 125I-LDL degradatioin was higher in cells from the normiial subjects than in cells fronm the FH heterozygotes.
Anl estimate of the reproducibility of the ymnphocyte assay wvas obtained by studying lymphocytes fromii the same subject on two differenlt occasionis. WVheni lymiphocv-tes from 8 nornmal subjects were each assayedl on two differenit days (47-355 days apart), the average xvariation between the two values for high affinity 1251-LDL degradation was 16%. 1251-LDL degradatiotii ifreshly isola ted cells. In all of the above studies, the lymphocytes were incubated for 67 h in the absence of lipoproteins to stimuilate the cells to prodtuce a relatively large numtiber of' LDL receptors. Thus, these studies do not indicate howv! manv LDL receptors were actually, expressed on these cells while they' were in the body. This latter measuiremiienit is more diffictult sinice lymphocytes niormally express only a small percentage of their maximal LDL receptor activity when they are initially isolated froml the bloodstream (8) . This stuppressioni of LDL receptor activity in vivo presumably resuilts from the presenice of LDL in the plasma in xvhich the lymphocy7tes have been circulating (8) .
Because of the regulation of LDL receptors, reliable measuremenit of the level of LDL receptor activity in freshly isolated cells from normal stubjects and FH heterozygotes necessitated the developmenit of a second protocol. In order to shorten the isolationi procedlure, lymphocytes were not separated from monoocytes. Rather, degradation activity was measured in a mixed population of mononuclear cells. The senisitivity of the assay was increased by incubating a larger number of mononuclear cells with 1251-LDL at a 2.5-fold higher concentration (25 Ag of protein/ml) in a final incubation volume that was reduced by 50% (1 ml). The data in Fig. 7 show that when monontuclear cells from a normal subject were isolated and incubated in this fashion, they degraded 1251-LDL by a process that could be coImlpetitively inhibited by the presence of anl excess of unlabeled LDL. After a brief initial lag phase, the rate of degradation was essentially linear for the first 6 h, after which it increased somewhat over the subsequeint 6 h. Because of the relatively short incubation time involved, a larger number of cells could be used while at the same time maintaining a linear rate of degradation. Thus, as shoxvn in Fig. 8 , the rate of degradation in these freshly isolated mononiuclear cells was linear up to a concentration of at least 4 x 106 cells/ml. Relation between the plasma LDL-cholesterol level and the rate of high affinity degradation of 125I-LDL in lymphocytes incubated in the absence of lipoproteins. The values plotted are obtained from the data in Table III : (0) healthy subjects; (A), hyperlipidemic subjects with disorders other than FH; and (0) FH heterozygotes. Blood samples for lymphocyte isolation and for measurement of plasma LDL-cholesterol level were obtained simultaneously. Replicate dishes of cells (4 x 106 cells/ml; 1 ml/dish) were prepared according to method B and incubated with 25 ,vg of protein/ml of 1251-LDL (219 cpm/ng) in the absence (0) or presence (0) of 500 ,ug of protein/ml of unlabeled LDL. After incubation at 37°C for the indicated interval, the content of 125Ilabeled acid-soluble material in the medium was determined as described in Methods. Each value represents the mean of triplicate incubations.
The experiment shown in Table IV was performed to test the hypothesis that the number of LDL receptors measured under the above assay conditions reflected the number actually present when the cells were initially isolated and was not attributable to receptors synthesized during the 3 h required for isolation of the mononuclear cells. In this experiment a blood specimen from one subject was divided into two portions immediately after removal from the body. The mononuclear cells were isolated from one portion according to the standard procedure (method B) in which the cells are not exposed to LDL during the isolation procedure. The other portion of blood was treated differently in that all solutions with which the cells came into contact during the isolation procedure contained 100 gg of protein/ml of LDL. This concentration of LDL is fully saturating for the LDL receptor, and its presenice has been shown previously to prevent the induction of LDL receptors that otherwise occurs when lymphocytes are deprived of the lipoprotein (8) . Immediately after the isolation procedure was completed (about 3 h after removal of the cells from the bloodstream), the cells were centrifuged to remove the unlabeled LDL and then incubated for 4 h in the presence 690 Bilheimer, Ho, Browtn, Anderson, and Goldstein of 25 ,ug of protein/ml of 125I-LDL. The rate of high affinity 1251-LDL degradation was the same in the cells isolated in the absence and presence of unlabeled LDL (Table IV) , indicating that the LDL receptors had not been synthesized in response to deprivation of LDL during the isolation procedure. To confirm that the added LDL was sufficient to suppress the synthesis of new LDL receptors, a portion of the mononuclear cells isolated in the absence or presence of LDL was further incubated for 9 h in the absence or presence of LDL, respectively. The cells were then isolated by centrifugationi and incubated for 4 h with 1251-LDL. In the cells that had been incubated in the absence of LDL, the rate of 1251-LDL degradation increased by fourfold during the 9-h interval (23 vs. 5.6 ng of 1251-LDL degraded in 4 h per 4 x 1(6 cells). In the cells incubated in the presence of LDL, this induction of LDL receptor activity was prevented, and the rate of 125I-LDL degradation actually declined somewhat (3.6 vs. 5.7 ng of 125I-LDL degraded in 4 h per 4 x 106 cells). The initial lag in the rate of degradation that was observed when freshly isolated mononuclear cells were incubated with 1251-LDL ( Fig. 7) raised the possibilitv that the observed LDL receptors were actually being synthesized during the time in which the cells were incubated with 1251-LDL. To examine this ques- 
CELL CONCENTRATION
(number x 10-6/ml) FIGURE 8 Degradation of 1251-LDL byI mononuclear cells immnediately after their isolation from the bloodstream plotted as a funcetion of the coincentrationi of cells in the incubation mlediumil. NIononuclear cells were isolated from 50 ml of venous blood obtained from a healthy subject (No. 16). Dishes of cells were prepared according to method B, except that the cot)centration of cells in each dish was varied from )0. , the content of 1251-labeled acid-soluble material in the medium was determined as described in Methods. A second portion ofthe cell suspension (1 ml) was placed into petri dishes and incubated at 37°C for 9 h in the absence (A-2) or presence (B-2) of 100 ,ug of protein/ml of unlabeled LDL. After this incubation, the medium was removed, each dish was washed once with 2 ml of medium A containing 30% human lipoprotein-deficient serum, and the wash was pooled with the original medium. The nonadherent cells were collected by centrifugation of the medium and wash. Each cell pellet was then suspended in 1 ml of medium A containing 30% lipoprotein-deficient serum and added back to the original dish so that the original adherent and nonadherent cells were present in the final incubation. Each dish was then incubated with 25 ,g of protein/ml of 1251-LDL (205 cpm/ng protein) either in the absence or presence of 500 ,ug of protein/ml of unlabeled LDL. After incubation for 4 h at 37°C (9-13 h incubation), the content of '25I-labeled acid-soluble material in the medium was determined as described in SMethods. Each value represents the average of triplicate incubations. tion, we compared the time course of high affinity 1251_ LDL degradation in freshly isolated mononuclear cells incubated with 125I-LDL at 25 gg/ml and 100 jig/ml. As demonstrated above (Table IV ) and in previous studies (8) , the latter concentration of LDL is sufficient to completelv prevent the induction of LDL receptors. Fig. 9A shows that the rate of high affinity degradation and the apparent lag phase were similar at the two concentrations of 1251-LDL, suggesting that the lag phase was not due to the induction of new LDL receptors during the Genetics of the Lotw Density Lipo protein Receptor incubation. To confirm this conclusion, we compared the initial time course in freshly isolated cells ( Fig. 9A ) with the initial time course of 125I-LDL degradation in lymphocytes that had been incubated for 67 h in the absence of lipoproteins so as to induce a large number of LDL receptors (Fig. 9B ). The lag phase in the induced cells was similar to that in the freshly isolated cells. The length of this lag phase is similar to the 30-60-min lag phase observed for 1251-LDL degradation in cultured human fibroblasts (6, 15) . In fibroblasts, this lag has been shown to be duie to the time required for the binding, internalization, and delivery of 1251_ LDL to cellular lysosomes and the subsequent release of 1251-monoiodotyrosine into the culture medium (15, 19, 23) .
Using the conditions of a 4-h incubation, a cell concentration of 4 x 106/ml and an 125I-LDL concentration of25 ,ug of protein/ml, we compared the rate of 1251-LDL degradation in freshly isolated mononuclear cells from a group of 13 healthy subjects, 4 subjects with hyperlipidemia other than FH, 6 FH heterozygotes, and 1 FH homozygote. The data in Table V demonstrate mean ±SD rates of high affinity LDL degradation among the healthy subjects and the hyperlipidemic subjects without FH were not significantly differenit (5. 7±1.3 and 5.6± 1.1 ng in 4 h per 4 x 106 cells, respectively). However, the mean ±SD rate of high affinity LDL degradation among the FH heterozygotes (3.1 +0.5) was significantly lower than that of both the healthy subjects and the hyperlipidemic subjects without FH (P < 0.001). The lowest value for high affinity degradation (0.9) was observed in the onie subject with homozygous FH.
DISCUSSION
In the current studies, LDL receptor activity in blood lymphocytes from normal subjects and FH heterozygotes was compared under two different assay conditions. First, the activity in isolated lymphocytes was measured after the cells had been incubated for 3 days in lipoprotein-deficient serum. This assay measures the genetic capacity of the cells to produce high levels of receptor activity in response to a strong stimultus. Sec- . Replicate dishes containing 4 x 106 cells in 1 ml of medium were prepared according to method B and incubated with 125I-LDL (300 cpm/ng) at 25 ,ug of protein/ml (A) or 100 ,ug of protein/ml (0). The incubations were conducted in the absence or presence of 1 mg of protein/ml of unlabeled LDL. After incubation at 37'C for the indicated interval, the content of 125I-labeled acid-soluble material in the medium was determined as described in Methods. ond, receptor activity was measured in a mixed population of mononuclear cells (consisting of 85-95% lymphocytes and 5-15% monocytes) immediately after their isolation from the bloodstream. This assay represents an attempt to measure the number of LDL receptors that were functional in these cells while they were in the body. Under both sets of assay conditions, the rate of high affinity 1251-LDL degradation was used as an index of the number of functional LDL receptors.
In both cases, the number of LDL receptors in the FH heterozygote cells was reduced as compared with that of the normal cells. The data in Fig. 6 , which reflect the capacity of lymphocytes to produce LDL receptors after incubation in lipoprotein-deficient serum, support the conclusion that the number of functional genes at the LDL receptor locus is one of the major factors determining the plasma LDL-cholesterol level in man (23) . As a group, lymphocytes from the FH heterozygotes, which express only one functional gene at the LDL receptor locus, produced less than 50% of the normal number of LDL receptors. Likewise, the mean LDL-cholesterol level in the FH heterozygote group was 2.5-fold above the mean LDL-cholesterol of the normal subjects (Table III). However, among individual persons within both the normal and FH heterozygote groups, the plasma LDL-cholesterol level varied by as much as two-to threefold. Moreover, the number of LDL receptors varied threefold within each group, even though the number of functionally active genes for the LDL receptor is presumably the same among all members within the same group (i.e., two per cell for the normals and one per cell for the heterozygotes). Within each group no relation was observed between the capacity of lymphocytes to produce LDL receptors and the plasma LDL-cholesterol level (Fig. 6 ). In other words, those normal subjects whose cells can develop the highest numbers of LDL receptors in vitro do not necessarily manifest the lowest levels of plasma LDLcholesterol. These data are consistent with previous studies of receptor-negative FH homozygotes, which have shown a twofold variation in plasma LDL-cholesterol levels (450-960 mg/dl) even among a group of subjects whose fibroblasts show no detectable ability to produce LDL receptors (4). Thus, the genetic capacity to produce LDL receptors dictates the general range of the plasma LDL-cholesterol level (i.e., 60-180, 180-400, and 450-1,000 mg/dl in normals, FH heterozygotes, and FH homozygotes, respectively [3, 4] ), but other factors determine the precise LDL-cholesterol level within a given range. It is known that diet, obesity, and age are among the nongenetic factors that influence plasma LDL-cholesterol levels among both normals and FH heterozygotes (24) .
The second set of assay conditions that was used in the current studies represented an attempt to estimate the number of LDL receptors actually produced by lymphocytes while they were circulating in the bloodstream. We have previously demonstrated that this number is much less than the number of receptors produced by cells when they are incubated in vitro in the absence of lipoproteins (8) . This is presumably because circulating lymphocytes are continuously exposed to high levels of LDL in the bloodstream and the resultant availability of cholesterol keeps LDL receptor activity suppressed (8, 9) . Because ofthis regulation ofthe LDL receptor, it has been difficult to obtain an accurate estimate of the number of LDL receptors on freshly isolated lymphocytes. It has also been difficult to exclude the possibility that the measured receptor activity in freshly isolated cells represents receptors that have developed in the cells during the time required for their isolation from the bloodstream (which takes about 3 h) or during their incubation with 125I-LDL.
In the current studies, we have modified our methods in two ways in an attempt to get around these problems. First, we shortened the isolation procedure by omitting any attempt to separate monocytes from lymphocytes. Instead, we studied a mixed population of moinonuclear cells, 85-95% of which were lymphocytes. Second, we increased the sensitivity of the assay by increasing the number of cells per assay, increasing the concentration of 125I-LDL, and decreasing the incubation volume.
Two types of experiments were conducted to test the possibility that the observed LDL receptors were induced during the time required for the isolation ofthe cells or were produced during the time of incubation of the cells with 125I-LDL. In the first experiment, cells were kept in cointact with a saturating level of LDL (100 ,ug of protein/ml) throughouit the isolation procedure. The presence of this concenitration of LDL was sufficient to prevent the indtiction of LDL receptors that otherwise occurred when the lymphocytes were incubated for a further 9 h in the absence of lipoproteins. However, the presence of this unlabeled LDL during the isolation procedure did not affect the 1251_ LDL degradation activity that was measured immediately after the cells were isolated, indicatinig that this activity was not induced as a result ofthe deprivation of the cells from LDL during this isolation procedure.
In the second experiment, we compared the time course of high affinity 125I-LDL degradation in freshly isolated cells and in cells that had beeni incubated for 67 h in the absence of lipoproteins so as to induce a high level of receptor activity. In both cases, the rate of degradation was essentially linear for 3 h after a 30-to 60-min lag period that corresponds to the time required to bind, take up, and degrade the 1251-LDL. Considered together, these two validation experiments suggest that the measured 125I-LDL degradation activity in freshly isolated blood mononuclear cells does reflect the nunm-ber of LDL receptors that were presenit on these cells while they were in the circulation. However, ultimate proof that these measurements do in fact represenit LDL receptors expressed in vivo will re(uire the development of sensitive methods for measuring the low levels of 1251-LDL binding activity in lymphocytes immediately after their isolation from the bloodstream.
When assayed by the above method, the activity of the LDL receptor in lvmphocytes at zero time w\as less thani one-twentieth of the activity that developed after 3 days of incubation in lipoprotein-deficienit serum. When the data are expressed on a per cell basis and normalized to an 125I-LDL concenitration of 10 u.g/ ml, the 1251-LDL degradation activity averaged 0.14 ng/ h per 106 cells initially (Table V) , as compared with 3 ng/h per 106 cells in the induced state (Table III) .
Monontuclear cells from FH heterozygotes as a group expressed only 55% of the normal number of LDL receptors when initially isolated from the bloodstream (Table V) . This 45% reductioni in LDL receptor activity correlates with the 50% reduiction in the total-body fractional catabolic rate for '251-LDL in FH heterozvgotes as originally mieasured by Lainger et al. in studies of plasma LDL turnover (25) . The current data lend support to the conclusion previously drawn from studies in fibroblasts that the reduction in LDL receptors in familial hypercholesterolemnia produices a relative block in the catabolism of LDL and that this defect is of fuindamental importance in catusinig the high plasma LDL levels in heterozvgotes and homnozygotes with this disease (2) (3) (4) .
A word of caution should be expressed with regard to the ability of the lymphocyte 125I-LDL degradation assay to distinguish betweeninormal subjects and FH heterozygotes if such an assay were to be applied to large-scale studies of the general population. The current studies primarily inivolved heterozygotes in one large family. Moreover, the numiiber of normiial subjects and FH heterozygotes studiedl was roughly comiiparable. Under these conditionis, there wvas little overlap letween the values for 125I-LDL degraclationi obtainied from FH heterozygotes and nornmal subjects (Fig. 6 ). However, aioinoig the general population, the ratio of normal subjects to FH heterozygotes is of the order of 500:1 (3, 26) . Hence, among the general population a borderline low 1251-LDL degradation value will mlore likely be attributable to a normal subject who is at the extreme lower limit of the Gaussian distributioni f'or normiial subjects rather thain to an FH heterozygote. Thus, as pointed ouit by Kirknman (27) , it is likely that some normal subljects would be imiisdiagnosed as heterozygotes if the assay were applied to the populationi at large. However, using both the level of'plasmiia LDLcholesterol (which is a goocl discriminiiant in its owni right) ancd the level of LDL receptor activity in inceuibated lymphocytes ats diagnostic criteriia, one shouild be able to distinguish between FH heterozygotes and normal subjects in the general population.
